Pre-treatment with GnRH agonists for 36 months prior to ovarian stimulation may improve ART outcomes by reducing pelvic inflammation
Potent Antioxidant and Anti-inflammatory Actions: ALCAR acts as a potent antioxidant, scavenging free radicals and reducing oxidative stress within the brain and throughout the body
10.3389/fendo.2021.721135 Summary Keywords lymphedema, GLP-1R agonists, GLP-1R agonist, GLP-1RAs, cancer-related lymphedema, Ozempic, semaglutide, liraglutide Citation Brown S, Tadros AB, Montagna G, Bell T, Crowley F, Gallagher EJ and Dayan JH (2024) Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND)
Injectable options usually offer greater weight loss, while oral versions promise greater day-to-day ease